×

Cramer: JNJ Prostate Cancer Drug Better Than Dendreon's

9:21 AM ET Thu, 8 March 2012

CNBC's Jim Cramer explains why Johnson & Johnson's prostate cancer drug is better and cheaper than Dendreon's drug.